{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:18:07Z","timestamp":1759936687059},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,11,18]],"date-time":"2006-11-18T00:00:00Z","timestamp":1163808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,11,18]],"date-time":"2006-11-18T00:00:00Z","timestamp":1163808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1007\/s00404-006-0280-6","type":"journal-article","created":{"date-parts":[[2006,11,17]],"date-time":"2006-11-17T06:26:32Z","timestamp":1163744792000},"page":"433-438","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of Yasmin in premenstrual symptoms"],"prefix":"10.1007","volume":"275","author":[{"given":"Surasak","family":"Taneepanichskul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Unnop","family":"Jaisamrarn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vorapong","family":"Phupong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,11,18]]},"reference":[{"key":"280_CR1","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/S0002-9378(98)70290-X","volume":"179","author":"Anonymous","year":"1998","unstructured":"Anonymous (1998) An open-label, multicenter, noncomparative safety and efficacy study of Mircette, a low-dose estrogen-progestin oral contraceptive. The Mircette Study Group. Am J Obstet Gynecol 179:S2\u2013S8","journal-title":"Am J Obstet Gynecol"},{"key":"280_CR2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/ejc.8.1.37.51","volume":"8","author":"D Apter","year":"2003","unstructured":"Apter D, Borsos A, Baumgartner W, Melis GB, Vexiau-Robert D, Colligs-Hakert A, Palmer M, Kelly S (2003) Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms. Eur J Contracept Reprod Health Care 8:37\u201351","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"280_CR3","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0025-7125(16)30011-6","volume":"79","author":"KT Barnhart","year":"1995","unstructured":"Barnhart KT, Freeman EW, Sondheimer SJ (1995) A clinician\u2019s guide to the premenstrual syndrome. Med Clin North Am 79:1457\u20131472","journal-title":"Med Clin North Am"},{"key":"280_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S0149-2918(00)88272-7","volume":"21","author":"PJ Boerrigter","year":"1999","unstructured":"Boerrigter PJ, Ellman H, Dolker M (1999) International clinical experience with a new low-dose, monophasic oral contraceptive containing levonorgestrel 100\u00a0microg and ethinyl estradiol 20\u00a0microg. Clin Ther 21:118\u2013127","journal-title":"Clin Ther"},{"key":"280_CR5","first-page":"79","volume":"48","author":"J Borenstein","year":"2003","unstructured":"Borenstein J, Yu HT, Wade S, Chiou CF, Rapkin A (2003) Effect of an oral contraceptive containing ethinyl estradiol and drospirenone on premenstrual symptomatology and health-related quality of life. J Reprod Med 48:79\u201385","journal-title":"J Reprod Med"},{"key":"280_CR6","first-page":"14","volume":"47","author":"C Brown","year":"2002","unstructured":"Brown C, Ling F, Wan J (2002) A new monophasic oral contraceptive containing drospirenone. Effect on premenstrual symptoms. J Reprod Med 47:14\u201322","journal-title":"J Reprod Med"},{"key":"280_CR7","first-page":"183","volume":"58","author":"JE Daugherly","year":"1998","unstructured":"Daugherly JE (1998) Treatment strategies for premenstrual syndrome. Am Fam Physician 58:183\u2013192","journal-title":"Am Fam Physician"},{"key":"280_CR8","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/01.grf.0000135298.39050.b3","volume":"47","author":"DL Dell","year":"2004","unstructured":"Dell DL (2004) Premenstrual syndrome, premenstrual dysphoric disorder, and premenstrual exacerbation of another disorder. Clin Obstet Gynecol 47:568\u2013575","journal-title":"Clin Obstet Gynecol"},{"key":"280_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0010-7824(97)00025-5","volume":"55","author":"J Endrikat","year":"1997","unstructured":"Endrikat J, Muller U, Dusterberg B (1997) A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20\u00a0micrograms ethinylestradiol\/75\u00a0micrograms gestodene and 30\u00a0micrograms ethinylestradiol\/75\u00a0micrograms gestodene, with respect to efficacy, cycle control, and tolerance. Contraception 55:131\u2013137","journal-title":"Contraception"},{"key":"280_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0306-4530(92)90058-F","volume":"17","author":"E Eriksson","year":"1992","unstructured":"Eriksson E, Sundblad C, Lisjo P, Modigh K, Andersch B (1992) Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls. Psychoneuroendocrinology 17:195\u2013204","journal-title":"Psychoneuroendocrinology"},{"key":"280_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1080\/13625180008500387","volume":"5","author":"JM Foidart","year":"2000","unstructured":"Foidart JM, Wuttke W, Bouw GM, Gerlinger C, Heithecker R (2000) A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel. Eur J Contracept Reprod Health Care 5:124\u2013134","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"280_CR12","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00006842-198607000-00002","volume":"48","author":"CM Logue","year":"1986","unstructured":"Logue CM, Moos RH (1986) Perimenstrual symptoms: prevalence and risk factors. Psychosom Med 48:388\u2013414","journal-title":"Psychosom Med"},{"key":"280_CR13","first-page":"181","volume":"12","author":"ML Moline","year":"1993","unstructured":"Moline ML (1993) Pharmacologic strategies for managing premenstrual syndrome. Clin Pharm 12:181\u2013196","journal-title":"Clin Pharm"},{"key":"280_CR14","volume-title":"Menstrual distress questionnaire manual","author":"RH Moos","year":"1991","unstructured":"Moos RH (1991) Menstrual distress questionnaire manual. Western Psychological Service, Los Angeles"},{"key":"280_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1749-6632.1995.tb31386.x","volume":"761","author":"P Muhn","year":"1995","unstructured":"Muhn P, Fuhrmann U, Fritzemeier KH, Krattenmacher R, Schillinger E (1995) Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Ann N Y Acad Sci 761:311\u2013335","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl3","key":"280_CR16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/14730782.2000.12288986","volume":"5","author":"W Oelkers","year":"2000","unstructured":"Oelkers W (2000) Drospirenone\u2014a new progestogen with antimineralocorticoid activity, resembling natural progesterone. Eur J Contracept Reprod Health Care 5(Suppl3):17\u201324","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"280_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.mce.2003.10.030","volume":"217","author":"W Oelkers","year":"2004","unstructured":"Oelkers W (2004) Drospirenone, a progestogen with antimineralocorticoid properties: a short review. Mol Cell Endocrinol 217:255\u2013261","journal-title":"Mol Cell Endocrinol"},{"key":"280_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0010-7824(00)00083-4","volume":"61","author":"KS Parsey","year":"2000","unstructured":"Parsey KS, Pong A (2000) An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen. Contraception 61:105\u2013111","journal-title":"Contraception"},{"key":"280_CR19","volume-title":"Premenstrual syndrome: a clinician\u2019s guide","author":"SK Severino","year":"1989","unstructured":"Severino SK, Moline ML (1989) Premenstrual syndrome: a clinician\u2019s guide. Guilford press, New York"},{"key":"280_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1034\/j.1600-0412.2000.079005405.x","volume":"79","author":"H Sveindottir","year":"2000","unstructured":"Sveindottir H, Backstrom T (2000) Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives. Acta Obstet Gynecol Scand 79:405\u2013413","journal-title":"Acta Obstet Gynecol Scand"},{"key":"280_CR21","volume-title":"Improving access to quality care in family planning. Medical eligibility criteria for contraceptive use methods","author":"World Health Organization (WHO)","year":"1996","unstructured":"World Health Organization (WHO) (1996). Improving access to quality care in family planning. Medical eligibility criteria for contraceptive use methods. World Health Organization, Geneva"},{"key":"280_CR22","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","volume":"106","author":"KA Yonkers","year":"2005","unstructured":"Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A (2005) Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet Gynecol 106:492\u2013501","journal-title":"Obstet Gynecol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-006-0280-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-006-0280-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-006-0280-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-006-0280-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T09:33:45Z","timestamp":1707384825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-006-0280-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,18]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["280"],"URL":"https:\/\/doi.org\/10.1007\/s00404-006-0280-6","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,18]]},"assertion":[{"value":"29 June 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}